BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21358543)

  • 1. Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk.
    Nordestgaard BG; Tybjærg-Hansen A
    Curr Opin Lipidol; 2011 Apr; 22(2):113-22. PubMed ID: 21358543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride-rich lipoproteins and HDL: what do recent trials tell us?
    Stock J
    Atherosclerosis; 2013 Jun; 228(2):329-31. PubMed ID: 23623013
    [No Abstract]   [Full Text] [Related]  

  • 3. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipoprotein levels as predictors of cardiovascular death in women.
    Bass KM; Newschaffer CJ; Klag MJ; Bush TL
    Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of genetic determinants of low density lipoprotein levels on lipoprotein (a).
    Hegele RA; Sutherland S; Robertson M; Wu L; Emi M; Hopkins PN; Williams RR; Lalouel JM
    Clin Invest Med; 1991 Apr; 14(2):146-52. PubMed ID: 1829402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progeny's lipid and lipoprotein levels by parental mortality. The Lipid Research Clinics Program Prevalence Study.
    Glueck CJ; Laskarzewski PM; Suchindran CM; Chambless LE; Barrett-Connor E; Stewart P; Heiss G; Tyroler HA
    Circulation; 1986 Jan; 73(1 Pt 2):I51-61. PubMed ID: 3940684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
    Nordestgaard BG
    Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms associated with cholesterol and risk of cardiovascular events.
    Kathiresan S; Melander O; Anevski D; Guiducci C; Burtt NP; Roos C; Hirschhorn JN; Berglund G; Hedblad B; Groop L; Altshuler DM; Newton-Cheh C; Orho-Melander M
    N Engl J Med; 2008 Mar; 358(12):1240-9. PubMed ID: 18354102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjustment of direct high-density lipoprotein cholesterol measurements according to intercurrent triglyceride corrects for interference by triglyceride-rich lipoproteins.
    Perera NJ; Burns JC; Perera RS; Lewis B; Sullivan DR
    J Clin Lipidol; 2010; 4(4):305-9. PubMed ID: 21122664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoproteins and homocyst(e)ine as risk factors for atherosclerosis: assessment and treatment.
    Frohlich JJ
    Can J Cardiol; 1995 May; 11 Suppl C():18C-23C. PubMed ID: 7750044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipids and lipoproteins associations with ABO blood groups.
    Contiero E; Chinello GE; Folin M
    Anthropol Anz; 1994 Sep; 52(3):221-30. PubMed ID: 7993068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.
    Musunuru K; Kathiresan S
    Circ Res; 2016 Feb; 118(4):579-85. PubMed ID: 26892959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular disease-related serum lipid parameters in a Hungarian subpopulation].
    Szépvölgyi J; Kravják BE; Bíró L; Nagy K; Bíró G; Antal M
    Orv Hetil; 1997 Aug; 138(32):2005-8. PubMed ID: 9297170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
    J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.
    Hokanson JE; Austin MA
    J Cardiovasc Risk; 1996 Apr; 3(2):213-9. PubMed ID: 8836866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of cholesterol concentrations of major serum lipoprotein classes in haemodialysis patients by anion-exchange chromatography.
    Hirowatari Y; Yoshida H; Fueki Y; Ito M; Ogura Y; Sakurai N; Miida T
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):571-4. PubMed ID: 18782818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women, lipoproteins and cardiovascular disease risk.
    LaRosa JC
    Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
    Schwandt P
    Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoproteins and cardiovascular risk--from genetics to CHD prevention.
    Cullen P; Funke H; Schulte H; Assmann G
    Eur Heart J; 1998 Apr; 19 Suppl C():C5-11. PubMed ID: 9597420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.